Phase 3 Study of BI 207127 in Combination With Faldaprevir and Ribavirin for Treatment of Patients With Hepatitis C Infection, Including Patients Who Are Not Eligible to Receive Peginterferon: HCVerso2
Clinical trial NCT01728324 · COMPLETED
Trial details
- NCT number
- NCT01728324
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2014-02-01
- Enrollment
- 496
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.